Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10hydroxydecy l)-1,4-benzoquinone
Details for Australian Patent Application No. 2007286491 (hide)
International Classifications
Event Publications
26 February 2009 PCT application entered the National Phase
PCT publication WO2008/019769 Priority application(s): WO2008/019769
27 August 2009 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor to read from Vancan, Pierre to Vankan, Pierre
24 June 2010 Application Accepted
Published as AU-B-2007286491
21 October 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser